scholarly journals Abnormal Mitochondrial Dynamics—A Novel Therapeutic Target for Alzheimer's Disease?

2010 ◽  
Vol 41 (2-3) ◽  
pp. 87-96 ◽  
Author(s):  
Bo Su ◽  
Xinglong Wang ◽  
David Bonda ◽  
Gorge Perry ◽  
Mark Smith ◽  
...  
2006 ◽  
Vol 2 ◽  
pp. S588-S588
Author(s):  
Yasumasa Ohyagi ◽  
Katsue Miyoshi ◽  
Ma Linqing ◽  
Kyoko Motomura ◽  
Takeshi Tabira ◽  
...  

2019 ◽  
Vol 116 (3) ◽  
pp. 427a-428a
Author(s):  
Hope Holt ◽  
Elizabeth Moore ◽  
Madeline Riese ◽  
Michelle Faucett ◽  
Francisco Gonzalez ◽  
...  

2006 ◽  
Vol 2 ◽  
pp. S591-S591
Author(s):  
Martin J. Sadowski ◽  
Joanna Pankiewicz ◽  
Henrieta Scholtzova ◽  
Hueizhi Wu ◽  
Frances Prelli ◽  
...  

2018 ◽  
Vol 13 (5) ◽  
pp. 930 ◽  
Author(s):  
Zhi-You Cai ◽  
Zun-Yu Ke ◽  
Ming Xiao ◽  
SohelH Quazi

2018 ◽  
Vol 46 (4) ◽  
pp. 891-909 ◽  
Author(s):  
Ruby Macdonald ◽  
Katy Barnes ◽  
Christopher Hastings ◽  
Heather Mortiboys

Mitochondrial abnormalities have been identified as a central mechanism in multiple neurodegenerative diseases and, therefore, the mitochondria have been explored as a therapeutic target. This review will focus on the evidence for mitochondrial abnormalities in the two most common neurodegenerative diseases, Parkinson's disease and Alzheimer's disease. In addition, we discuss the main strategies which have been explored in these diseases to target the mitochondria for therapeutic purposes, focusing on mitochondrially targeted antioxidants, peptides, modulators of mitochondrial dynamics and phenotypic screening outcomes.


2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Naotaka Izuo ◽  
Chihiro Kasahara ◽  
Kazuma Murakami ◽  
Toshiaki Kume ◽  
Masahiro Maeda ◽  
...  

2011 ◽  
Vol 82 (10) ◽  
pp. 1500-1509 ◽  
Author(s):  
Fan Zeng ◽  
Jian-Jun Lu ◽  
Xin-Fu Zhou ◽  
Yan-Jiang Wang

2010 ◽  
Vol 177 (3) ◽  
pp. 1422-1435 ◽  
Author(s):  
Maya K. Desai ◽  
Michael A. Mastrangelo ◽  
Deborah A. Ryan ◽  
Kelly L. Sudol ◽  
Wade C. Narrow ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document